Analysts expect Regeneron Pharmaceuticals, Inc. to report revenue of 5.65 B for Q4 26, against a range of 5.42 B to 5.87 B. The most recent reported quarter, Q3 26, came in at 5.12 B, a 9.3% beat against the 4.69 B consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 3.79 B | 3.03 B | 3.68 B | 3.75 B | 3.88 B | 3.61 B | 4.29 B | 5.12 B | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 4.33 B | 3.77 B | 3.41 B | 3.49 B | 4.18 B | 3.59 B | 4.14 B | 5.05 B | 5.87 B | 5.05 B | 5.80 B | 5.84 B | 6.57 B | 5.37 B | 5.36 B | 5.63 B | |||||||||
| Low Estimate | 3.67 B | 3.13 B | 2.93 B | 3.23 B | 3.87 B | 3.13 B | 3.89 B | 4.32 B | 5.42 B | 4.63 B | 4.76 B | 5.30 B | 5.75 B | 4.60 B | 4.69 B | 4.63 B | |||||||||
| Consensus Estimate | 4.00 B | 3.45 B | 3.17 B | 3.36 B | 4.02 B | 3.36 B | 4.01 B | 4.69 B | 5.65 B | 4.84 B | 5.28 B | 5.57 B | 6.16 B | 4.98 B | 5.03 B | 5.13 B |
Analysts expect Regeneron Pharmaceuticals, Inc. to report earnings per share of 26.57 for Q4 26, against a range of 24.42 to 28.72. The most recent reported quarter, Q3 26, came in at 20.07, a 30.5% beat against the 15.38 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 12.07 | 8.22 | 12.89 | 11.83 | 11.44 | 9.47 | 14.29 | 20.07 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 10.91 | 9.59 | 8.39 | 10.87 | 12.06 | 9.79 | 11.13 | 16.25 | 28.72 | 18.20 | 20.96 | 22.16 | 27.92 | 16.95 | 21.29 | 19.76 | |||||||||
| Low Estimate | 10.23 | 8.81 | 7.61 | 9.37 | 10.06 | 8.81 | 9.67 | 14.51 | 24.42 | 15.48 | 18.46 | 18.96 | 25.60 | 13.95 | 17.83 | 17.76 | |||||||||
| Consensus Estimate | 10.57 | 9.20 | 8.00 | 10.12 | 11.06 | 9.30 | 10.40 | 15.38 | 26.57 | 16.84 | 19.71 | 20.56 | 26.76 | 15.45 | 19.56 | 18.76 |
Pull Wall Street consensus for Regeneron Pharmaceuticals, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=REGN&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "REGN", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=REGN&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();